Department of Ophthalmology, Poznań University of Medical Sciences, Poznań, Poland.
Polyclinic of Plastic and Ophthalmic Surgery, Kobylniki, Poland.
BMC Ophthalmol. 2023 Dec 12;23(1):506. doi: 10.1186/s12886-023-03246-z.
To investigate the frequency and location of additional primary malignancies in a Polish cohort of uveal melanoma (UM) patients registered in a single centre database.
Retrospective data analysis of patients treated for uveal melanoma at the Department of Ophthalmology, Poznań University of Medical Sciences, Poland between 1991 and 2017. Data on the diagnosis of the additional malignancies were obtained during the follow-up visits in our Department and/or from the Greater Poland Cancer Registry. The exclusion criteria comprised no confirmed follow-up or incomplete clinical entry data.
Among 644 UM patients registered in the database up to 2017, the additional malignancy was diagnosed in 126 (20%) patients: 71 men, 55 women at the median age of 67 years (range: 34-94). In 48 patients (38%), the additional malignancy occurred prior to the diagnosis of UM, in 73 (58%) patients - after it. The most common locations of second cancer were skin (20 cases / 15%), breast (17 cases / 13%) and lungs (15 cases / 12%). The median follow-up was 36 months (range: 3-242). 87 patients (69%) died by the study close, 32 (37%) of them due to metastatic disease from uveal melanoma, 41 (47%) due to another cancer.
The frequency of additional primary malignancies was higher in our cohort than reported by most of other groups. If there is a certain predisposition to a specific type of additional primary carcinoma in UM patients, the analysis of larger database is required.
在波兰一个单中心数据库中登记的葡萄膜黑色素瘤(UM)患者队列中,调查额外原发性恶性肿瘤的发生频率和部位。
对 1991 年至 2017 年期间在波兰波兹南医科大学眼科接受治疗的葡萄膜黑色素瘤患者进行回顾性数据分析。在我们的科室随访期间或从大波兰癌症登记处获得有关额外恶性肿瘤诊断的数据。排除标准包括无确认随访或不完整的临床条目数据。
在截至 2017 年登记在数据库中的 644 名 UM 患者中,有 126 名(20%)患者被诊断出患有其他恶性肿瘤:男性 71 名,女性 55 名,中位年龄为 67 岁(范围:34-94)。在 48 名患者(38%)中,额外恶性肿瘤发生在 UM 诊断之前,在 73 名患者(58%)中发生在 UM 诊断之后。第二癌症最常见的部位是皮肤(20 例/15%)、乳房(17 例/13%)和肺部(15 例/12%)。中位随访时间为 36 个月(范围:3-242)。在研究结束时,有 87 名患者(69%)死亡,其中 32 名(37%)死于转移性 UM 疾病,41 名(47%)死于另一种癌症。
在我们的队列中,额外原发性恶性肿瘤的发生率高于大多数其他研究报道。如果 UM 患者存在某种特定类型的额外原发性癌的易感性,则需要对更大的数据库进行分析。